Skip to main content
Christine Fallabel on Muck Rack

Christine Fallabel

Denver
As seen in: Diabetes Strong, Healthline Media, diaTribe, Healthline, NewsBreak, Beyond Type 1, Diabetes Daily, T1D Exchange, Beyond Type 2
writer. public health. mostly mountains, running & vegetables. type 1 diabetes. thoughts & views my own.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Christine

Contact Christine, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

GLP-1s for Type 1 Diabetes? What the First Expert Guidelines Say

|
By Christine Fallabel
| Beyond Type 1
For years, people living with type 1 diabetes (T1D) have experienced insulin resistance, burnout, frustrating high blood sugar levels, weight gain and food cravings without much response from the medical community. When someone is diagnosed with T1D, there is significant beta cell loss, blood sugars are dangerously high and symptoms are present.
Open in Who Shared Issue with article?

Surviving Summer Heat with T1D

|
By Christine Fallabel
| Beyond Type 1
Summer means a lot of things: no school, longer days, more sunshine and warmer weather. But if you live with type 1 diabetes (T1D), it can also mean more preparation for the heat, humidity, and the sticky, sweltering days that can make T1D more difficult. Besides making managing blood sugars harder, for those tethered to insulin pumps or continuous glucose monitors (CGMs), the daily dance of “will my adhesive stick today?” can turn simple summertime into more of a headache than you planned for.
Open in Who Shared Issue with article?

No Needles, No Pre-Bolus: Afrezza Is Now Approved for Kids 6 And Older With Diabetes

|
By Christine Fallabel
| Beyond Type 1
Parents of children and teens living with type 1 and type 2 diabetes, your daily routine is about to get a lot easier. Afrezza, the first inhaled and only needle-free mealtime insulin, has been approved by the Food and Drug Administration (FDA) for use in children aged 6 and older living with type 1 and type 2 diabetes. This is a remarkable change for people and children living with diabetes.
Open in Who Shared Issue with article?
See all 209 articles